BioLineRx Ltd.
Alış
Güncellendi

BLRX-BREAKOUT-UPDATE

389
BLRX had a strong rally today and it's just getting started.

In the related idea my price target was $1.34.

Today's high was $1.78

Check out the weekly chart:

ekran görüntüsü

Photo Finish.

$1.34 was 1.618 extension level from Waves 1 & 2.

Since the price-action broke $1.34 we will have an extended 3rd wave.

I expect a very strong rally tomorrow, I will update in the morning before the open to confirm.

Target is hard to predict since its impossible to know what level extending waves will terminate.

I will keep a close eye on the price-action.

Will update.

-AB






Not
As expected, a very strong rally today!
Not
ekran görüntüsü
Not
We got a big runway...
Not
Reminder this is a WEEKLY chart...

Meaning this move is far from over...
Not
ekran görüntüsü
Not
Buckle up!
Not
ekran görüntüsü
Not
Target $2.24 (Sell Half)

Trade Price: 1.049
Not
ekran görüntüsü
Not
ekran görüntüsü
Not
Bull Flag
Not
BLRX will rally again tomorrow.
Not
ekran görüntüsü
Not
BLRX is about to rally again...
Not
BLRX continued to consolidate today.

Staying the course...
Not
ekran görüntüsü
Not
ekran görüntüsü
Not
Near-Term Target: $2.13
Not
ekran görüntüsü
Not
Primary Wave 1 Complete
Not
ekran görüntüsü
Not
03:21 PM EDT, 10/22/2018 (MT Newswires) -- Oppenheimer has kept its outperform rating on BioLineRx (BLRX) with a price target of $3, betting on BL-8040's commercial opportunity as a stem cell mobilizer after top-line data from the COMBAT/KEYNOTE-202 trial of BL-8040 in combination with pembrolizumab in advanced pancreatic cancer showed modest response rate.
"Given the combination's favorable safety profile, BioLineRx and Merck (MRK) are testing a triplet combination including chemotherapy in an effort to increase response rate," analyst Mark Breidenbach said in a note.
"While we believe the triplet combination is worth testing, our valuation of BioLineRx still remains focused on BL-8040's commercial opportunity as a stem cell mobilizer."
Not
ekran görüntüsü
Not
ekran görüntüsü
Not
Breakout Imminent
Not
ekran görüntüsü

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.